TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read moreDiaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP7.5 million for the six months that ended on June 30, up 25% from GBP6.0 million a year earlier. Says more than 75% of revenue generated through the company's DXRX platform, up 60% from 2021. Diaceutics says half-year revenue and order book growth are in line with expectations.
Read more(Alliance News) - Diaceutics PLC on Monday it will deliver customised data insights to a "top five global" pharmaceutical firm under a new contract.
Read more(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights via its DXRX platform.
Read moreDiaceutics PLC - UK testing laboratories company - Announces "significant enhancements" to its DXRX platform in order to improve user experience. Company says customers will now be able to access three new AI-powered tools to ensure medicines get to patients quicker.
Read moreDiaceutics PLC - UK testing laboratories company - Wins five-year contract worth at least USD1 million with an unnamed "top 30 global" pharmaceutical company, in a multi-product subscription for customised data insights via its DXRX platform. Contract expands existing relationship with the company, and sets stage for future opportunities, it says. Says its offering of customised biomarket test results and interpretation was a key draw for the client, with the client's needs in oncology to be served by DXRX Signal.
Read more(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its 'DXRX' platform.
Read more(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - Diaceutics PLC said on Tuesday it swung to a pretax profit in 2021 and posted an increase in annual revenue.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read moreDiaceutics PLC - UK testing laboratories company - Wins data subscription contract with an unnamed "top five global life sciences company" worth over USD2.5 million, with proceeds to be realised over its three-year term. Says it is its largest data subscription contract to date.
Read moreDiaceutics hails DXRX platform for strong annual sales and earnings
Read moreIN BRIEF: Diaceutics hails USD1 million subscription contract win
Read more